ANIKA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.41 USD | -1.32% |
|
-2.57% | +12.14% |
| 08/05 | Transcript : Anika Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
| 08/05 | Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 EPS $0.09 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 38Cr | - | - | - | |||
| 8.92TCr | ||||||
| 4.05TCr | ||||||
| 3.28TCr | ||||||
| 2.62TCr | ||||||
| 1.45TCr |
